Ginsenoside Rg3 and suramin, another anticancer drug, also have obvious inhibitory effects on angiogenesis induced by lung cancer. In vitro cell experiments show that ginsenoside Rg3 has a strong inhibitory effect on the metastasis of mouse ascites hepatoma cells, melanoma cells and human small cells. Lung cancer cells and human pancreatic cancer. The inhibitory effect of ginsenoside Rg3 on tumor metastasis is related to its inhibition of tumor cell infiltration, adhesion and anti-angiogenesis.
Many experimental results show that ginsenoside Rg3 can significantly improve the immune function of normal mice and tumor-bearing mice, prolong the survival time of tumor-bearing mice, and has synergistic and attenuated effects with radiotherapy and chemotherapy. At present, ginsenoside Rg3 has been widely used in the field of anti-cancer.
See this article for details. Ginsenoside Rg3 inhibits cancer.